OBJECTIVE: Limited data is available regarding subsequent pregnancy outcomes after maternal-fetal surgery via hysterotomy. The objective of this study was to ascertain obstetric risk in subsequent pregnancies after open fetal surgery (OFS) for myelomeningocele (MMC) closure. STUDY DESIGN: An international multicenter registry (North American Fetal Therapy Network/ fMMC Consortium Outcomes Registry) was created to track and report maternal, obstetric, fetal/ neonatal and subsequent pregnancy outcomes following maternalfetal surgery for MMC. Subsequent pregnancy outcome variables were collected via maternal questionnaire. Data are collected from each center and entered into a combined de-identified dataset using REDCap. Subsequent pregnancy outcomes data were analyzed using descriptive statistics. Centers participating in the registry obtained local IRB approval and executed data use agreements. RESULTS: A total of 52 subsequent pregnancies in 40 women were reported after OFS for MMC. Of these 40 women, 32 had 1 subsequent pregnancy, 5 women had 2, 2 women had 3, and 1 woman had 4 pregnancies after OFS, all singleton gestations. There are 10 that are ongoing or have missing outcome data. The live birth rate among those with complete data was 63%. Among the 52 subsequent pregnancies, 7 (13.5%) resulted in miscarriage < 20 weeks. Of the 35 pregnancies progressing > 20 weeks EGA, uterine rupture occurred in 11.4% (4/35) and OFS uterine incision thinning/ dehiscence was described in 8.6% (3/35) at delivery. The mean GA at uterine rupture was 29 weeks (range 26-32); Two fetal deaths were reported as a result of uterine rupture. Placenta accreta was reported in a single case. Among live births, the mean GA at delivery was 36.2 weeks (range 26.4-38.4). Blood transfusion at delivery was required in 11.1%. All patients delivered via cesarean with 89.2 % via a low transverse uterine incision. Recurrence of fetal spina bifida was noted in 2 pregnancies. CONCLUSION: The risk of uterine rupture or dehiscence, with its associated risk of fetal morbidity and mortality, in subsequent pregnancies after open fetal surgery is significant. This risk should be included in the pre-operative counseling for patients who are candidates for maternal-fetal surgery. The risk for abnormal placentation requires additional investigation. Guidelines for management of pregnancies following OFS should be developed to address these risks.
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2 Resource utilization among low-risk nulliparas randomized to elective induction at 39 weeks or expectant management OBJECTIVE: To evaluate medical resource utilization for lowerisk nulliparous women randomized to elective induction of labor (IOL) at 39 weeks compared to those randomized to expectant management (EM). STUDY DESIGN: Planned secondary analysis of a multi-center RCT in which low-risk nulliparous women were assigned to IOL at 39 0/7 -39 4/7 weeks or EM. Resource utilization after randomization was categorized a priori according to when resources were used e antepartum, delivery admission, and from discharge until through 8 weeks postpartum e and compared according to group assignment. RESULTS: Of 6096 women with data available, 3059 were randomized to IOL and 3037 to EM. During the antepartum period, after randomization, those in the IOL group were less likely to have at least one ambulatory visit for routine prenatal care, for unanticipated office care, or to urgent care/ED/triage, as well as to have an inpatient admission for at least one day (Table 1, p < .001 for all). These cumulatively accounted for 3650 fewer ambulatory visits, 40 fewer inpatient days, and 2072 fewer blood, sonogram, and antenatal surveillance tests for women in the IOL group prior to delivery (Table 2) . During the delivery admission, women in the IOL group spent a longer duration in L&D, and received cervical ripening, oxytocin, and IUPCs more frequently; conversely, they received fewer MgSO 4 and antibiotic infusions, had a shorter postpartum stay, and had neonates who less frequently used CPAP/HFO 2 and who had shorter hospital stays (Table 1, P < .05 for all). Neonates in the IOL group were more likely to have 1 ambulatory office visit other than for routine neonatal care (Table 1 , p < .05); otherwise, women and neonates in both groups had similar frequencies of postpartum urgent care or ED visits, and hospital readmissions (p > .05 for all). CONCLUSION: Although women randomized to IOL spent more time in L&D and used more resources specific to IOL (e.g., cervical ripening), they had significantly fewer antepartum visits and tests, intrapartum therapeutic interventions (e.g., MgSO 4 ) and shorter postpartum maternal and neonatal hospital stays. Thus, the antepartum and postpartum burden of resource utilization related to EM of low-risk nulliparous women beyond 39 weeks is substantial, and is important to account for in comparing.
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